Maps

The art world is moving closer to endorsing psychedelics research as witnessed by Nashville-born Daniel Donato’s U.S. concert tour VIP ticket donations. Whether or not you're familiar with his music, his personal story is truly compelling. As a...

(Part four of a four-part series) In addition to psilocybin’s therapeutic value, ongoing discussion involves other issues such as how its potential commercialization process is unfolding. In terms of ethics, Numinus (OTCMKTS: NUMIF) co-founder and CEO Payton...

The United States Sentencing Commission (USSC), which establishes and advises Congress on federal sentencing guidelines, has reached a full panel enrollment for the first time since 2014 and, more importantly, a quorum for the first time in three years, which will allow the group to finally...

Health Canada has just completed a review of all active MDMA-assisted psychotherapy trials, in response to alleged patient safety issues and research flaws. The issues had resulted in one of the two existing studies being suspended while the other allowed to proceed with some "corrective...

MAPS, an NGO leading research in the psychedelics space, is launching “Psychedelic Fundamentals,” an online psychedelic education program providing "accurate, evidence-based information on psychedelics," now available for purchase on the organization's...

Cartography of the Mind has raised over $1.5 million. Proceeds of this single-largest philanthropic art sale presented by Christie’s in collaboration with Ryan Zurrer (Dialectic and Vine Ventures) will benefit MAPS’ psychedelics research. The exhibition of the digital art...

The freshest news traversing many of the major institutions, researchers' and activists’ accounts on Twitter is the recent release of a docu-series based on writer Michael Pollan’s 2018 book “How To Change Your Mind: What the science of psychedelics teaches us...

Christie’s, the legendary art and luxury auction house, along with Dialectic and Vine Ventures, will auction off NFT works for those interested in digital art and supporting scientific studies. In this case, the research is related to the legalization of psychedelic...

The non-profit Multidisciplinary Association for Psychedelics Studies (MAPS) and its subsidiary MAPS Public Benefit Corporation finished the enrollment stage for the second Phase 3 clinical trial on MDMA (MAPP2). A year later after publishing the results from its first Phase 3 trial...

Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock.  In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy.  At the...

The Drug Enforcement Administration (DEA) will face activists at its headquarters in Arlington, Virginia, reported Mary-Elizabeth Gifford and Justin Grant of Lucid News. Protestors intend to block the entrance to the building to call attention to the rights of terminally ill...

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted...

Michael Mullette, a former Moderna (NASDAQ: MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. The MAPS PCB is a for-profit company wholly owned by the Multidisciplinary Association for Psychedelic...

The UK’s Medicines and Healthcare Products Regulatory Agency has granted an “Innovation Passport” to the drug MDMA, also known as “ecstasy” or “molly,” in the treatment of post-traumatic stress disorder. The Innovation Passport, part of the Innovative...

Novamind Inc. (OTCQB: NVMDF) a mental health company specializing in psychedelic medicine, recently announced a strategic investment and advisory agreement with Bienstar Wellness Corp, an Uruguay-based mental health company, to assist in the expansion of Latin America's first network of...